Although transdermal drug delivery has been used for about three decades, the range of therapeutics that are administered this way is limited by the barrier function of the stratum corneum (the top layer of skin). Microneedle arrays have been shown to increase the drug permeability in skin by several orders of magnitude by bypassing the stratum corneum. This 15 can potentially allow the transdermal delivery of many medicaments including large macromolecules that typically cannot diffuse through the skin. This paper addresses the use of microneedles coated with a drug solution film. In particular, we identify how the geometries of various microneedles affect the drug permeability in skin. Effective skin permeability is calculated for a range of microneedle shapes and dimensions in order to identify the most 20 efficient geometry. To calculate effective permeability (P eff ), the effective skin thickness (H eff ) is calculated. These are then plotted for insulin as a model drug to see how various microneedle parameters affect the profiles of both H eff and P eff . It is found that the depth of penetration from the microneedle array is the most important factor in determining P eff , followed by the microneedle spacings. Other parameters such as microneedle diameter and 25 coating depth are less significant.
Introduction
Transdermal drug delivery (TDD) seems to be in clinical use since 1981 (Kumar and Philip, 2007) . The first transdermal patch was developed by Alza Corporation as a treatment for motion sickness (Tojo, 1987) . Since then, patches have been used in applications such as hormonal therapy, pain relief and as an aid to smoking cessation. Such patches allow the 35 controlled release of drugs over several hours or even days. This is in contrast to bolus drug delivery (i.e., administration of a single large dose), such as by use of a hypodermic needle in intravenous delivery whereby the drug is immediately delivered systemically.
Drug delivery via the parenteral route, either by intravenous or intramuscular injection, is 40 particularly common. Injection by hypodermic needle has been 'the gold standard' for drug delivery for over a century (McAllister et al., 2003) . But, it has a number of disadvantages associated with it. Hypodermic needles often cause pain, transmit pathogens through needle re-use and require medical expertise to use (Gill and Prausnitz, 2007) . Transdermal drug delivery is both painless and user-friendly. Another common method of drug delivery is via 45 the oral route (e.g. taking tablets). However, many drugs such as insulin are severely degraded by digestion processes and as such cannot be administered in an oral formulation (Ito et al., 2006) . Drugs administered through TDD avoid gut and first pass liver metabolism, improving drug bioavailability (Xie et al., 2005) . However, while TDD offers numerous advantages, its use has been very limited due to the small range of drugs that can be effectively delivered this 50 way. Even though blood circulation is close to the skin surface, the skin is very well adapted to prevent infectious substances entering the body. This is largely due to the outer layer of skin, the stratum corneum. In order to passively diffuse through this layer, drug molecules must be of a low molecular weight (< 500Da) and hydrophobic. Even if these conditions are met, the drug must be potent so that the small amounts that can be delivered are sufficient 55 (Gill and Prausnitz, 2007) . When considering a model for transdermal diffusion, it is usually assumed that the skin acts as a bi-layer membrane which consists of the stratum corneum and the viable skin. Drug that permeates through the viable skin is rapidly absorbed by the microcirculation (Tojo, 1987) . It 60 is clear that the stratum corneum is the main barrier to diffusion through the skin. The diffusion coefficient of drug molecules within the stratum corneum is usually at least 500 -10,000 times smaller than within the viable skin (Tojo, 1987) . In general, there are several ways in which its barrier ability can be reduced or bypassed and hence achieving better transdermal drug delivery. These include electroporation (Sen et al., 2002) , phonophoresis
In addition to the methods mentioned previously, skin permeability can also be enhanced through the use of microneedles (Kim and Lee, 2007) . Arranged into an array, these are 75 micron-scale projections that penetrate through the stratum corneum, creating a superficial pathway through which drugs can reach the deeper levels of the skin. The working principle of the microneedle arrays has been discussed in a number of previous papers (Prausnitz, 2004; . Till date, four methods of transdermal delivery mediated by microneedles have been attempted (Gill and Prausnitz, 2007): 80 (i) Applying an array of microneedles to first permeabilize the skin before using a traditional transdermal patch.
(ii) Coating the microneedles with a drug containing film before inserting into the skin.
(iii) Creating the microneedles from a polymeric material that contains the drug. The drug is 85 then released in a controlled manner after insertion into the skin.
(iv) Injection through hollow microneedles.
The first three methods utilise solid microneedles and the last method relies on a liquid formulation being injected through hollow microneedles. Hollow microneedles have generally 90 received less attention to date as they are inherently structurally weaker and have practical problems such as the bore hole being clogged by tissue (Wang and Cornwell, 2006) . This paper will focus on the second method, the so-called "coat and poke" approach (Prausnitz, 2004) as shown in Figure 1 .
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Recently, there has been an interest to investigate the influences of a variety of variables related to the microneedles to reach the optimum microneedle design and hence, improve the transdermal drug delivery when using microneedle arrays. Many relevant factors have been considered to formulate an optimized microneedle arrays, including the mask shape of the microneedle (Wilke and Morrissey, 2007) , location of the microneedle hole (Khumpuang et 100 al., 2007) , the microneedle tip radius (Teo et al., 2006) , etc. However, most of these studies made their decision based on different criteria such as microneedle insertion, but not skin permeability, although skin permeability has been considered as a key factor that determines the efficiency of transdermal drug delivery process (Wilke et al., 2006) .
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Our previous study showed the effect of various parameters (e.g., number of microneedles, microneedle radius, etc) influencing the permeability of skin . This has been done by developing an optimization algorithm to determine the optimum microneedle dimensions of both hollow and solid microneedles. Skin thickness based on different classifications (e.g., race, sex, etc) has been correlated with skin permeability (Al-110 . In another study, we proposed a mathematical framework which provides quantitative evaluations of various parameters influencing the drug concentration in blood . A scaling analysis has also been done which describes the functional dependency of drug concentration on other variables of skin and microneedle arrays . Following from these studies, this work aims to quantify the 115 influence of various geometrical parameters (e.g., microneedle thickness, coating depth, etc) associated with six microneedle shapes of coated drugs on the effective skin permeability with a view to identify the most effective geometry of the micro-needles. The ratio (R P ) of drug permeability with microneedles to the permeability of normal skin (i.e., without microneedle arrays) has also been determined. This has been done to obtain more information 120 for designing microneedle arrays since that little quantitative research has been presented for determining skin permeability using microneedles (Wu et al., 2006) . This ratio helps to assess the ability of increasing skin permeability using microneedles. This parameters seems to be useful to compare various microneedles model, and hence, to achieve the optimum geometry.
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Modelling Strategy
Model Assumptions
For the purpose of this work, the following assumptions are made:
(1) The concentration of the drug (C) in the blood remains low throughout, and so the blood is considered to act as a sink, i.e. C = 0 for all time (t).
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(2) Skin binding is assumed to be negligible in the viable skin.
(3) Drug metabolism is assumed to be negligible in the viable skin.
(4) All drug molecules that diffuse through the viable skin are taken up by the microcirculation.
(5) The rate limiting step is diffusion through the viable skin.
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The first assumption can be considered to be realistic as drug coating solutions are generally many orders of magnitude greater than the drug plasma concentration. Skin binding involves drug molecules becoming bound to active sites on macromolecules, which can cause a reduction of the diffusion coefficient to an 'effective value' that is a function of drug concentration (Tojo, 2005) . Drug binding tends to be prevalent in the stratum corneum rather 140 than the viable skin, so ignoring it is a reasonable approximation.
Metabolism by the living cells in the viable skin however can lead to an appreciable decrease in the systemic delivery of the drug (Tojo, 2005) . To our best knowledge, there is no data to quantify the effect of skin metabolism on various drugs, particularly for those drugs that have 145 not typically been used in transdermal delivery before. In one study, the pharmacological availability of insulin delivered by drug-loaded polymer microneedles was found to be between 91-98% when compared to intravenous dosing. In many practical cases, it may be possible to prevent metabolism, as demonstrated by Sintov and Wormser (2007) . Iodine was used to deactivate skin glutathione so that insulin could retain its potency as it permeated 150 through. As the objective of this paper is to compare microneedle designs, metabolism of drugs in the viable skin is ignored for simplicity.
The fourth assumption defines that 100% of the drug molecules that diffuse into the area of skin occupied by the microcirculation (taken to be 200 µm deep) are absorbed into the blood.
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This is a common assumption and is considered realistic (see, e.g., Tojo, 1987) .
The final assumption defines that the rate at which the drug dissolves into the tissue fluids and the rate at which it is absorbed by the blood is rapid compared to the rate at which it diffuses through the viable skin. This is a fair approximation, as the coating should be a mainly 160 aqueous solution and will quickly dissolve into the skin's tissues (i.e., within 20 seconds) according to Gill and Prausnitz (2007) . Drug molecules should also be quickly absorbed into the blood, especially in vivo (Tojo, 1987) .
Governing Equations for Drug Transport in Skin 165
For solid microneedles coated by an aqueous solution of drug molecules, the rate-limiting step is the transport of drugs through the viable epidermis. Drug molecules dissolve in the interstitial fluids of the skin and diffuse towards the microcirculation in the dermis. It is assumed that absorption by the blood is rapid compared to permeation through the skin (Tojo, 1987) . In order to determine the effective skin permeability, and hence, the effective skin 170 thickness, Fick's first law has been adopted:
Where J is the flux of drug through the skin, D is the diffusion coefficient of drugs in skin, C is the concentration of diffusing drug and dx dC is the concentration gradient.
At steady state (i.e. 0 dt dC = ) it can be defined that, 175
Here, H is the thickness of the skin after microneedles have been inserted, C 2 is drug concentration at the bottom of epidermis layer and C 1 is drug concentration at the tip of microneedles. Now, combining Fick's first law (equation 1) with equation (2), we obtain an expression for steady state diffusive flux J ss as follows:
Where P is the drug permeability in skin. When C 2 is defined to be zero (i.e., sink condition) J ss is given by:
For coated microneedles, the drug permeability is increased by bypassing the stratum corneum. This leaves the drug to diffuse across the viable skin (which consists of the viable epidermis and dermis) into the blood microcirculation. Assuming steady state transport across skin (Park et al., 2005) , the effective permeability P eff of the skin when coated microneedles are being used is calculated by:
Where D vs is the diffusion coefficient of the drug in the viable skin which is assumed to be constant (i.e., the diffusion coefficients in the viable epidermis and dermis are of the same magnitude) (Tojo, 1987) and H eff is the effective thickness of the skin after microneedles have been inserted. Therefore, H eff is a function of purely of microneedle geometry. The effective permeability of a drug due to microneedles can be compared with its permeability through normal skin that has its stratum corneum intact. By considering the skin to act as a bilayer membrane (Tojo, 1987) , the permeability of intact skin is found by 200 reciprocal addition of the permeability of the two layers, the stratum corneum and viable skin as follows:
Where R is the resistance, P skin is skin permeability, D sc and D vs are diffusion coefficients of 205 stratum corneum and viable skin, respectively while H sc and H vs are thicknesses of stratum corneum and viable skin, respectively. The resistance implies the inverse of permeability.
The ratio (R P ) of permeability with microneedles to the permeability of normal skin is given by dividing equation (8) by equation (6) as follows:
Where, R D is the ratio of diffusion coefficients in the viable skin and stratum corneum. This value is typically 500 -10,000 (Tojo, 1987) .
Microneedles Models
215
For the purpose of this work, six microneedle shapes have been chosen, as shown in Table 1 and 
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Microneedle model F is a triangular type microneedle proposed by Martanto et al. (2004) as shown in Figure 2 (F). The tip angle is maintained at 79.9° as the geometry is varied.
Method of solution
Drug diffusion from coated microneedles is modelled in 3D using FEMLAB, a piece of 235 scientific modelling software from Comsol (Comsol, 2005) . It allows equation-based multiphysics modelling in an interactive environment. Free-form partial differential equations can be set up or particular physics applications can be chosen, in this case diffusion. 3D geometry of the microneedles can then be drawn and the diffusion of drug molecules analysed in transient or steady state. This is done by performing finite element analysis on the domain 240 of interest. The domain is discretised into a mesh of small 3D elements, usually tetrahedrons.
Our results show that the mesh is accurate enough, so that refining it did not significantly change the results. Boundary conditions and subdomains parameters are set and the PDE's that characterise the physics of the domain are converted into ordinary differential equations. In order to model the diffusion process from the coated microneedles into the skin, the diffusion model was used in FEMLAB as shown in Figure 3 where the standard dimensions for the FEMLAB model, in this case are microneedle model A. CD is the coating depth of drug on the microneedle (i.e., the distance from the tip that is coated by the drug film). As a standard, this is 100 µm, as seen in literature (Widera et al., 2006) . S is the width and length 250 of the square element of skin. It also represents the centre-to-centre spacing of the microneedles, assuming they are in a square pattern. As a standard, this distance was 100 µm.
The distance to the microcirculation from the skin surface has been reported as 200 µm (Tojo, 1987) and so that is used here. Similarly other models were also set up based on Table 1 and 
255
The skin is modelled as a single subdomain with an isotropic diffusion coefficient (D). It was found that having a layer to represent the stratum corneum did not significantly affect the results and so it is not included in the model for simplicity. The blood is assumed to act as a sink for the drug and so this boundary condition is set (concentration is set to zero on this 260 boundary).
The boundary conditions for the drug concentration at the surface of the coated microneedle
On the other hand, the boundary condition for the drug concentration at the bottom of the epidermis layer is,
Where a C is the drug concentration at the surface of the coated drug, u L is the uncoated microneedle length, L is the microneedle length, h is the epidermis thickness (i.e. equal to 200 270 µm), x is the distance in a given skin layer and t is time.
We calculate the steady state diffusive flux of drug through the blood interface assuming the concentration of drug on the needle is constant. It allows the calculation of effective skin thickness H eff , which is purely dependent on microneedle geometry. In our approach, H eff is 275 calculated using the following method. The flux term determined from the simulations is integrated over the microcirculation boundary and then divided by the boundary area to give an average steady state flux, J ss . By rearranging the steady state of Fick's first law, the following expression is found:
Where a C is the drug concentration at the surface area of the coated drug and H eff can then be used to calculate the effective skin permeability P eff in equation (6). It is assumed that the drug concentration at the surface area of the coated drug is 1% (w/v), which is 1 g/100 ml. This is a typical value from the work by Gill and Prausnitz (2007) . This value was kept the same in all cases.
285
By symmetry, it is possible to model a whole array of microneedles by modelling only a single microneedle. For instance, it can be shown that the flux of drug from one microneedle only needs to be multiplied by the number of microneedles in the array to give the total flux of drug. For example, an array of nine microneedles can be represented by the modelling a 290 single microneedle, due to symmetry. This is convenient as the geometry of the problem becomes considerably simpler. 3D modelling of complex geometry requires greater computer processing power and takes longer simulation time.
Results and Analyses
295
In the present work, the following geometrical parameters of the microneedles were varied: depth of penetration, diameter (microneedle models A and C), thickness (microneedle models D and E), coating depth, center-to-center spacing. In addition, hexagonal symmetrical elements were designed for microneedle models A and B to compare with the case of square elements. Skin is wrinkled and has various surface features such as hairs. In addition to the 300 visco-elasticity of the skin, this means that microneedles will not penetrate to their full length (McAllister et al., 2003) . In general, microneedles longer than 100 µm should be used to ensure that they penetrate beyond the stratum corneum (Stoeber and Liepmann, 2005) . As the microcirculation is located ~200 µm beneath the skin's surface in general, the microneedles should be shorter than this to prevent any chance of bleeding. For these reasons, the 
Effects of depth of penetration
The ability of controlling the depth of penetration has a significant limitation when using the microneedles of different geometries (Matriano et al., 2002) . It is therefore important to relate 315 microneedle dimensions to the penetration depth which then influence the performance of the microneedles for drug delivery process (Teo et al., 2005) . Widera et al. (2006) showed that coated microneedles with different drug doses did not decrease the penetration depth for a given microneedle length. However, the depth of penetration decreased with increased microneedles length for a given dose (Widera et al., 2006) . In contrast, Cormier et al. (2004) 320 compared the penetration depth for both coated and uncoated microneedles. In their study, they found a significant reduction in penetration depth for coated microneedles.
To address this issue in a systematic manner, the depth of microneedle penetration was varied for all types of microneedle to calculate the effective skin thickness H eff and effective skin Rajaraman and Henderson (2005) argued that the microneedle diameter depends on the materials used for fabrication. The experimental results conducted by Stoeber and Liepmann (2005) illustrated that microneedle diameter depends on the maximum microneedles density (i.e., number of microneedles per unit area). The force needed to cause microneedle failure 345 during piercing through skin increases by increasing microneedle diameter (Park et al., 2007) .
Effects of microneedle diameter
These results were consistent with the simulations presented by Haider et al. (2001) where the insertion force requirements increased with increasing microneedle diameter. Teo et al. (2005) demonstrated that increasing microneedle diameter improved transdermal drug transport. Microneedles tend to buckle for a given diameter and length by increasing 350 microneedles length but of the same diameter at pressure less than that needed to penetrate the stratum corneum (Mukerjee et al., 2004) . Microneedle with larger diameter provides higher mechanical stability than that with a smaller diameter (Ovsianikov and Chichkov, 2007) . Khumpuang et al. (2005) fabricated microneedles array with a microneedle diameter of 40 µm to prevent any problems appear in blood clogging due to the small diameter of while 355 blood cell (i.e., approximately more than 20 µm).
Following the above discussions, we investigated the influence of various microneedle diameters on both the effective skin thickness and effective skin permeability for various geometries. Figure 5 was obtained when the diameters of microneedles model A and model C 360 were varied. Besides diameter, the other dimensions are standard values (penetration depth = 140 µm, coating depth = 100 µm, microneedle spacing = 100 µm). It can be seen in Figure 5 that by increasing the diameter, the effective skin thickness is decreased, increasing the effective skin permeability. However, over the range of diameters tested, the effective skin thickness only changed by less than 10%, indicating the effective skin thickness is not a 365 strong function of the diameter. As the diameter is increased, the diffusion paths from the microneedle to the corners of the microcirculation interface are reduced. This is responsible for decreasing effective skin thickness and increasing effective skin permeability. Diameter may be more important in increasing the available surface area for drug coating on the microneedle. Effective skin permeability appears to tend to a constant value as diameter is 370 increased. For a given diameter, there is little difference in the effective skin permeability when either microneedle is considered. This is presumably due to the similarity of geometry in the two models.
Effects of microneedle thickness
375
The thickness of microneedle has been considered as an important parameter, since it is related to the length of microneedles and hence its strength (Rajaraman and Henderson, 2005) . Davis et al. (2004) found that the force of microneedle fracture depends on the microneedle thickness. They noticed that the margin of safety (i.e., ratio between microneedle fracture and skin insertion force) reached its highest value with large microneedle thickness.
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To determine the effects of this parameter, the thickness of microneedle models D-F was varied and the results are shown in Figure 6 . Standard dimensions were used in Table 1 . The results indicate that by increasing the thickness of these microneedles, effective skin thickness will decrease and permeability will increase. The range of effective skin thickness is quite 385 small for each microneedle (13-15%) when compared to the range that was obtained by varying length (>60%). This indicates effective skin thickness is a relatively weak function of thickness, like diameter. Unlike in the case of diameter though, effective skin permeability appears to be a linear function of thickness. The mechanism by which permeability is increased is probably due to the shortening of diffusion paths from the microneedle to the 390 corners of the microcirculation interface in the skin diffusion model.
Effects of microneedle drug coating depth
Gill and Prausnitz (2007) examined the ability of controlling the microneedle length by varying the coverage coating percentage of the microneedle length. However, they did not 395 study the influence of this variation on skin permeability. Widera et al. (2006) studied the effect of changing the coating dose for four microneedle array designs. They found that both the length and density of microneedles did not influence the total amount of drug delivered into the skin. The amount delivered of ovalbumin as a model protein increased as a result of increasing the coating concentration of ovalbumin (Matriano et al., 2002) . However, 400 decreasing the coating dose would improve the drug delivery efficiency (Cormier et al., 2004) .
In this study, the depth of drug coating was varied on all microneedles (with otherwise standard dimensions), between 40 to 120 µm. The effect on effective skin thickness and 405 permeability are shown in Figure 7 . For all cases, except microneedle model B, effective skin thickness and skin permeability are very weak functions of the coating depth of the drug film on the microneedle. As mentioned before, microneedle model A and microneedle model C were found to be indistinguishable so microneedle model C is not plotted. Beyond 60-80 µm it seems that effective skin thickness and effective skin permeability become independent of 410 coating depth. It is difficult to explain why coating depth appears to be more important in determining effective skin permeability for microneedle B than the other models.
Effects of microneedle spacing
As expected, the center-to-center distance between two adjacent microneedles is an important 415 factor for fabricating microneedles (Choi et al., 2006) . The insertion force of microneedles depends on microneedles spacing (Parker et al., 2007) . This accords well where the insertion force of microneedles depends on microneedles spacing as well as microneedle length (Davis et al., 2004) . They suggest that the insertion force depends also on the number of microneedles as long as the spacing is wide enough. Increasing the center-to-center spacing 420 improves the transdermal drug delivery efficiency of coated microneedles (Gill and Prausnitz, 2007) . Haider et al. (2001) also demonstrated this by increasing microneedle spacing which reduced penetration force. While the previous studies attempted to determine effects of microneedle spacing on the force of insertion, it not clears how the spacing influences the effective skin permeability and thickness.
To address this issue in this work, the centre-to-centre spacing was varied between 75-200 µm for all the microneedle models (with standard dimensions). From Figure 8 , it appears that an exponential relationship exists between microneedle spacing and both effective skin thickness and effective skin permeability. When each series of data is fitted to an exponential trend line, 430 the R 2 value is greater than 0.99, indicating a strong agreement. As spacing increases, the surface area of the microcirculation interface (where the sink condition exists) in each square symmetrical element of the microneedle array also increases. The diffusion paths from the microneedle surfaces in the centre of the element to the corners of the microcirculation interface become longer as the area of the interface increases. This is responsible for the 435 increase in effective skin thickness and hence the decrease in effective skin permeability. As stated before, the data for microneedle model C was indistinguishable from microneedle model A and so was not plotted.
Square or hexagonal microneedle array pattern
440
Since the first fabrication of microneedles, different microneedles array patterns have been proposed such as square (Hsu et al., 2007) , hexagonal (Widera et al., 2006) , etc. However, the shape of the pattern does not represent the shape of microneedle cross section (Rodriguez et al., 2005) . In this work, it was determined whether arranging the microneedles into a hexagonal pattern affected the effective permeability of skin. This was done by using 445 hexagonal shaped elements in the skin diffusion model instead of square ones. Therefore, the demonstration has been done for microneedle models A and D. Figure 9 indicates that for a given centre-to-centre spacing, effective skin permeability is slightly greater when a hexagonal array pattern is used over a square pattern. As mentioned previously, the relation between effective skin thickness and effective skin permeability with microneedle spacing is 450 an exponential increasing and decaying, respectively. For a given centre-to-centre microneedle spacing, the area of the microcirculation interface is greater for square elements.
As a result, the diffusion paths are then longer which results in a greater effective skin thickness.
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Effects of increase in skin permeability relative to untreated skin
Microneedle arrays have been considered as an intelligent drug delivery devices (Tao and Desai, 2003) . Over the past few years, a variety of methods have been proposed to determine the skin permeation of drugs caused by microneedles. Wu et al. (2006) used macroneedles instead of microneedles and determined permeability through treated skin by macroneedles.
460 Wu et al. (2007) compared permeability of high molecular compounds through treated skin by microneedle before and after applying the iontophoresis. This has been done by evaluating permeability factor (i.e., ratio of flux through fresh intact skin over flux post-iontophoresis).
However, as far as the authors know, no theoretical effort had ever been done for evaluating the relative skin permeability to quantify the changes before and after applying the 465 microneedles across skin. For that reason, we determine the ratio of permeability with microneedles and permeability of normal skin (R P ) which is a function of H eff , the effective skin thickness and R D , the ratio of diffusion coefficients in the viable skin and stratum corneum. As mentioned previously, the value of R D varies between 500 -10,000 (Tojo, 1987) .
The thickness of stratum corneum and viable skin were assumed to be 20 µm and 180 µm,
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respectively. This has been assumed since that the distance to the microcirculation from the skin surface has been reported as 200 µm (Tojo, 1987) . consistent with literature, which states that microneedles can improve skin permeability by over 1000 times when left in place (Henry et al., 1998) .
Conclusions
The geometry effects of various types of solid microneedles with insulin as a model drug have 480 been discussed in this paper. A framework has been presented in this paper to identify the best microneedle models used in transdermal drug delivery to increase skin permeability.
Microneedle model D was the best model in terms of penetration depth, microneedle thickness, coating depth and center-to-center spacing while, microneedle model A was the best model in terms of microneedle diameter. Effective skin thickness (H eff ) and permeability
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(P eff ) were calculated for various microneedle models. It was found that microneedle penetration depth was the most significant factor in determining these parameters. This is expected, as deeper microneedle penetration will directly shorten the drug diffusion paths from the microneedle surfaces into the microcirculation of the skin. Centre-to-centre spacing of the microneedles in the array also had a significant effect on effective permeability. The 490 other microneedle dimensions, the diameter in cylindrical needles, the thickness in flat needles, and the coating depths were less significant in determining P eff . In general, larger, longer and more densely packed microneedles will result in greater skin permeability, which is an intuitive result. Skin permeability was seen to be enhanced by around 3 orders of magnitude through use of microneedles in the model, which is consistent with practical 495 studies. This suggests that for designing microneedle arrays, considering the geometries of the microneedle arrays enhance efficiency of transdermal drug delivery techniques. The proposed relationship of both effective skin permeability and skin thickness allow us to predict the permeation across human skin and to correlate the microneedles geometries to deliver low/high molecular weight drug using microneedles. Further work should include practical experimental data and clinical trials to determine whether the models from this research accurately represent the real situation.
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